Pediatric therapeutics and medicine administration in resource-poor settings: A review of barriers and an agenda for interdisciplinary approaches to improving outcomes-Reference-Cited by-同舟云学术

Pediatric therapeutics and medicine administration in resource-poor settings: A review of barriers and an agenda for interdisciplinary approaches to improving outcomes

Published:2009-12 Issue:11 Volume:69 Page:1681-1690
ISSN:0277-9536
Container-title:Social Science & Medicine
language:en
Short-container-title:Social Science & Medicine

Author:

Craig Sienna R.,Adams Lisa V.,Spielberg Stephen P.,Campbell Benjamin

Publisher

Elsevier BV

Subject

History and Philosophy of Science,Health (social science)

Reference108 articles.

1. Efficacy and safety of artemether–lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial;Abdulla;Lancet,2008

2. Childhood tuberculosis in the developing world;Adams;Pediatric Annals,2004

3. Access denied to essential medicines in developing world;Ahmad;Lancet Infectious Diseases,2002

4. Gender difference in treatment seeking behaviors of tuberculosis cases in rural communities of Bangladesh;Ahsan;Southeast Asian Journal of Tropical Medicine and Public Health,2004

5. Adherence to antiretroviral therapy in children: a comparative evaluation of caregiver reports and physician judgment;Albano;AIDS Care,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of low-cost, weight-adjustable clofazimine mini-tablets for treatment of tuberculosis in pediatrics;European Journal of Pharmaceutical Sciences;2023-08

2. Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children;Pharmaceutics;2023-03-23

3. Safety of integrated preventive chemotherapy for neglected tropical diseases;PLOS Neglected Tropical Diseases;2022-09-29

4. Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?;Children;2022-07-27

5. Optimal Design, Characterization and Preliminary Safety Evaluation of an Edible Orodispersible Formulation for Pediatric Tuberculosis Pharmacotherapy;International Journal of Molecular Sciences;2020-08-10